These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33454803)

  • 1. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway.
    Xu L; Zhu S; Tang A; Liu W
    Inflamm Res; 2021 Feb; 70(2):217-227. PubMed ID: 33454803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo.
    Sun QX; Wang RR; Liu N; Liu C
    Pathol Oncol Res; 2020 Jul; 26(3):1549-1558. PubMed ID: 31482398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
    Peng X; Yan J; Cheng F
    Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of lncRNA ADPGK-AS1 on the proliferation and apoptosis of retinoblastoma cells by targeting miR-200b-5p].
    Xing F; Li YM; Gao MM
    Zhonghua Zhong Liu Za Zhi; 2023 Mar; 45(3):230-237. PubMed ID: 36944544
    [No Abstract]   [Full Text] [Related]  

  • 6. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway.
    Fu C; Wang S; Jin L; Zhang M; Li M
    Curr Eye Res; 2021 Jul; 46(7):978-987. PubMed ID: 33108919
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis.
    Su J; Chen D; Ruan Y; Tian Y; Lv K; Zhou X; Ying D; Lu Y
    Bioengineered; 2022 Mar; 13(3):6978-6995. PubMed ID: 35311623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis.
    Ni W; Li Z; Ai K
    Bioengineered; 2022 Jan; 13(1):1637-1649. PubMed ID: 34989314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis.
    Fu K; Zhang K; Zhang X
    Orphanet J Rare Dis; 2022 Mar; 17(1):119. PubMed ID: 35248107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating microRNA-191-5p/brain derived neurotrophic factor.
    Xu Y; Fu Z; Gao X; Wang R; Li Q
    Bioengineered; 2021 Dec; 12(1):1587-1598. PubMed ID: 33942699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/β-catenin pathway.
    He H; Qin M
    Clin Exp Pharmacol Physiol; 2020 May; 47(5):886-891. PubMed ID: 31990064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA ZFPM2-AS1 Knockdown Restrains the Development of Retinoblastoma by Modulating the MicroRNA-515/HOXA1/Wnt/β-Catenin Axis.
    Lyv X; Wu F; Zhang H; Lu J; Wang L; Ma Y
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):41. PubMed ID: 32561925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/AXIN2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical Cancer.
    Niu Z; Wang F; Lv S; Lv Y; Liu M; Fu L; Yao Y; Wang L; Lin W; Yuan F
    Mol Cell Biol; 2021 Sep; 41(10):e0011521. PubMed ID: 34309414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
    Liu S; Yan G; Zhang J; Yu L
    Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFAP1 antisense RNA 1 promotes retinoblastoma progression by sponging microRNA miR-545-3p that targets G protein subunit beta 1.
    Tang W; Zhang L; Li J; Guan Y
    Bioengineered; 2022 Mar; 13(3):5638-5652. PubMed ID: 35193469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis.
    Zhang H; Qiu X; Song Z; Lan L; Ren X; Ye B
    Anticancer Drugs; 2022 Jan; 33(1):e218-e227. PubMed ID: 34387590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.